MA50205A - Formulation de nicotine - Google Patents

Formulation de nicotine

Info

Publication number
MA50205A
MA50205A MA050205A MA50205A MA50205A MA 50205 A MA50205 A MA 50205A MA 050205 A MA050205 A MA 050205A MA 50205 A MA50205 A MA 50205A MA 50205 A MA50205 A MA 50205A
Authority
MA
Morocco
Prior art keywords
nicotine
formulation
Prior art date
Application number
MA050205A
Other languages
English (en)
Other versions
MA50205B1 (fr
Inventor
Joseph Kavanagh
Christopher Nolan
Brian O'rourke
Kieran Raleigh
Original Assignee
Yatzz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yatzz Ltd filed Critical Yatzz Ltd
Publication of MA50205A publication Critical patent/MA50205A/fr
Publication of MA50205B1 publication Critical patent/MA50205B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Manufacture Of Tobacco Products (AREA)
MA50205A 2018-06-01 2019-05-31 Formulation de nicotine MA50205B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18175640.4A EP3574902A1 (fr) 2018-06-01 2018-06-01 Formulation de nicotine et mode d'administration
PCT/EP2019/064212 WO2019229249A1 (fr) 2018-06-01 2019-05-31 Formulation de nicotine

Publications (2)

Publication Number Publication Date
MA50205A true MA50205A (fr) 2020-07-29
MA50205B1 MA50205B1 (fr) 2021-09-30

Family

ID=62528283

Family Applications (2)

Application Number Title Priority Date Filing Date
MA054714A MA54714A (fr) 2018-06-01 2019-05-31 Formulation de nicotine
MA50205A MA50205B1 (fr) 2018-06-01 2019-05-31 Formulation de nicotine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA054714A MA54714A (fr) 2018-06-01 2019-05-31 Formulation de nicotine

Country Status (13)

Country Link
US (2) US11833145B2 (fr)
EP (3) EP3574902A1 (fr)
JP (1) JP7224375B2 (fr)
CN (1) CN112218637A (fr)
AU (2) AU2019276357B2 (fr)
BR (1) BR112020024088B1 (fr)
CA (1) CA3099940A1 (fr)
ES (1) ES2883799T3 (fr)
MA (2) MA54714A (fr)
MX (1) MX2020012810A (fr)
PL (1) PL3684362T3 (fr)
SG (1) SG11202011761XA (fr)
WO (1) WO2019229249A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration
GB201817868D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
FR3102041A1 (fr) * 2019-10-22 2021-04-23 Aroma Sens Edulcorant pour liquides de cigarette électronique
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
EP3860696B1 (fr) 2019-12-15 2024-04-10 Shaheen Innovations Holding Limited Inhalateur ultrasonore de brume
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
WO2021123867A1 (fr) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Inhalateur de brume ultrasonore
US20240148053A9 (en) 2019-12-15 2024-05-09 Shaheen Innovations Holding Limited Hookah device
IL294000B (en) 2019-12-15 2022-09-01 Shaheen Innovations Holding Ltd Steam inhaler devices
WO2021123869A1 (fr) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Nébulisateur à ultrasons
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
EP4076025A1 (fr) * 2019-12-18 2022-10-26 Philip Morris Products, S.A. Formulation destinée à être utilisée dans un système de génération d'aérosol
JP2021122237A (ja) * 2020-02-05 2021-08-30 日本たばこ産業株式会社 液体加熱式の加熱型香味吸引器用の液体組成物
US20230107605A1 (en) 2020-03-27 2023-04-06 Mcneil Ab Cartridge with nicotine
WO2022129907A1 (fr) * 2020-12-15 2022-06-23 Shaheen Innovations Holding Limited Dispositifs inhalateurs à brume
MA65146B1 (fr) * 2020-04-06 2024-05-31 Shaheen Innovations Holding Ltd Dispositifs d'inhalateur de brouillard
CN111802686A (zh) * 2020-07-27 2020-10-23 湖北中烟工业有限责任公司 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟
CN111855866A (zh) * 2020-08-25 2020-10-30 甘肃烟草工业有限责任公司 一种快速测定烟用添加剂中甲醛的方法
CN113197330A (zh) * 2021-04-28 2021-08-03 深圳市博睿生物科技有限公司 一种电子烟新型甜味剂及制备方法及应用
IL283002A (en) * 2021-05-06 2022-12-01 Nicogen Ltd Nicotine formulations and aerosols
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves
CN116019250A (zh) * 2022-12-22 2023-04-28 东莞市吉纯生物技术有限公司 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法
WO2024138377A1 (fr) * 2022-12-27 2024-07-04 思摩尔国际控股有限公司 Liquide d'atomisation, atomiseur et dispositif d'atomisation électronique

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
CA2231968A1 (fr) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Methode de production d'un medicament a base de nicotine
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
CN114223928A (zh) * 2013-05-06 2022-03-25 尤尔实验室有限公司 用于气溶胶装置的烟碱盐调配物及其方法
UA122320C2 (uk) * 2013-07-19 2020-10-26 Олтріа Клайєнт Сервісиз Ллк Рідка аерозольна композиція для електронного курильного виробу
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration

Also Published As

Publication number Publication date
US20240050424A1 (en) 2024-02-15
MA54714A (fr) 2021-11-17
BR112020024088B1 (pt) 2022-10-11
CA3099940A1 (fr) 2019-12-05
SG11202011761XA (en) 2020-12-30
EP3684362A1 (fr) 2020-07-29
EP3574902A1 (fr) 2019-12-04
US11833145B2 (en) 2023-12-05
ES2883799T3 (es) 2021-12-09
WO2019229249A1 (fr) 2019-12-05
EP3684362B1 (fr) 2021-06-23
CN112218637A (zh) 2021-01-12
AU2023202855A1 (en) 2023-05-25
BR112020024088A2 (pt) 2021-02-17
JP7224375B2 (ja) 2023-02-17
JP2021526147A (ja) 2021-09-30
EP3909581A1 (fr) 2021-11-17
AU2019276357B2 (en) 2023-04-20
AU2019276357A1 (en) 2020-11-26
MA50205B1 (fr) 2021-09-30
MX2020012810A (es) 2022-03-08
US20210196700A1 (en) 2021-07-01
PL3684362T3 (pl) 2021-12-20

Similar Documents

Publication Publication Date Title
MA50205A (fr) Formulation de nicotine
DK3688162T3 (da) Formuleringer
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
MA50657A (fr) Formulations de niraparib
MA46180A (fr) Analogues de l'amyline
DK3498278T3 (da) Forbindelser til behandling af sygdomme relateret til DUX4-ekspression
DK3634377T3 (da) Farmaceutisk formulering
UA40089S (uk) Кальян
DK3651736T3 (da) Langtidsvirkende formuleringer
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3678644T3 (da) Formuleringer af copanlisib
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
DK3400017T3 (da) Kontinuerlig kompleksering af aktive farmaceutiske ingredienser
DK3601277T3 (da) Farmaceutisk formulering
DK3512518T3 (da) Buprenophinformuleringer med langvarig frigivelse
DK3173071T3 (da) Formularing af maropitant
DK3625231T3 (da) Derivatives of resiquimod
MA43166A (fr) Formulation de fviii
MA43126A (fr) Compositions pharmaceutiques de fumarate de diméthyle
DK3773501T3 (da) Intravaginal formulering
DK3519050T3 (da) Sammensætninger til behandling af oftalmiske sygdomme
DK3414211T3 (da) Gipssammensætning
ES1220991Y (es) Ahumador
UA36698S (uk) Набір форм для випікання
UA36697S (uk) Набір форм для випікання